On December 9, 2020 BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, reported that it will be presenting at the 13th annual LD Micro Main Event investor conference on Monday, December 14 at 9:40 AM PST / 12:40 PM EST (Press release, Biolase Technology, DEC 9, 2020, https://www.prnewswire.com/news-releases/biolase-to-present-at-the-13th-annual-ld-micro-main-event-conference-301189336.html [SID1234572557]). President and CEO Todd Norbe and Executive Vice President, CFO and COO John Beaver will be presenting to a live, virtual audience.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Register to attend the event here: ve.mysequire.com/
The Main Event will feature a new and unique format, with companies presenting for 10 minutes, followed by 10 minutes of Q&A by a panel of investors and analysts.
"The time has finally come to do something different in the virtual conference world. Let’s see if we can pull off something that can be enjoyed by both executives and investors alike," stated Chris Lahiji, Founder of LD, now a wholly owned subsidiary of SRAX, Inc.
The Main Event will take place on December 14th and 15th, exclusively on the Sequire Virtual Events platform.